Preclinical pharmacokinetic exploration of a novel osteoporotic quinazolinone-benzopyran-indole hybrid (S019-0385) using LC-MS/MS

References

• Alarcon-Barrera JC, Kostidis S, Ondo-Mendez A, Giera M. 2022. Recent advances in metabolomics analysis for early drug development. Drug Discov Today. 27 (6):1763–1773. doi: 10.1016/j.drudis.2022.02.018.
   PubMed Web of Science ®Google Scholar
• Amini AR, Laurencin CT, Nukavarapu SP. 2012. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 40 (5):363–408. doi: 10.1615/CritRevBiomedEng.v40.i5.10.
   PubMedGoogle Scholar
• Berthold EC, Kamble SH, Raju KS, Kuntz MA, Senetra AS, Mottinelli M, León F, Restrepo LF, Patel A, Ho NP, et al. 2022. The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study. Drug Metab Dispos. 50 (2):158–167. doi: 10.1124/dmd.121.000640.
   PubMed Web of Science ®Google Scholar
• Bhateria M, Ramakrishna R, Kumar Puttrevu S, Yerrabelli S, Saxena AK, Bhatta RS. 2016. Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 1031:154–162. doi: 10.1016/j.jchromb.2016.07.030.
   PubMed Web of Science ®Google Scholar
• Biswas A, Verma SK, Kumar S, Mishra T, Kumar M, Choudhury AD, Agrawal S, Sanap SN, Bisen AC, Mishra A, et al. 2023. Preclinical pharmacokinetics and cyp modulation activity of chebulinic acid: a potent molecule against metabolic disease. Curr Drug Metab. 24 (8):587–598. doi: 10.2174/1389200224666230817101950.
   PubMed Web of Science ®Google Scholar
• Chandasana H, Chhonker YS, Laxman TS, Prasad YD, Anil Kumar KS, Dikshit DK, Bhatta RS. 2016. Assessement of the pharmacokinetics, tissue distribution and excretion studies of a novel antiplatelet agent s007-867, following administration to rats. Drug Test Anal. 8 (7):723–729. doi: 10.1002/dta.1811.
   PubMed Web of Science ®Google Scholar
• Chandra A, Rajawat J. 2021. Skeletal aging and osteoporosis: mechanisms and therapeutics. Int J Mol Sci. 22 (7):3553. doi: 10.3390/ijms22073553.
   PubMed Web of Science ®Google Scholar
• Cheruvu HS, Yadav NK, Valicherla GR, Arya RK, Hussain Z, Sharma C, Arya KR, Singh RK, Datta D, Gayen JR. 2018. LC-MS/MS method for the simultaneous quantification of luteolin, wedelolactone and apigenin in mice plasma using hansen solubility parameters for liquid-liquid extraction: application to pharmacokinetics of Eclipta alba chloroform fraction. J Chromatogr B Analyt Technol Biomed Life Sci. 1081-1082:76–86. doi: 10.1016/j.jchromb.2018.01.035.
   PubMed Web of Science ®Google Scholar
• Chhonker YS, Chandasana H, Kumar A, Kumar D, Laxman TS, Mishra SK, Balaramnavar VM, Srivastava S, Saxena AK, Bhatta RS. 2015. Pharmacokinetics, tissue distribution and plasma protein binding studies of rohitukine: a potent anti-hyperlipidemic agent. Drug Res). 65 (7):380–387. doi: 10.1055/s-0034-1387774.
   Google Scholar
• Chhonker YS, Chandasana H, Mukkavilli R, Prasad YD, Sachin Laxman T, Vangala S, Bhatta RS. 2016. Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E- and Z-guggulsterone in rat. Drug Test Anal. 8 (9):966–975. doi: 10.1002/dta.1885.
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. 2019. Osteoporosis. Lancet. 393 (10169):364–376. doi: 10.1016/S0140-6736(18)32112-3.
   PubMed Web of Science ®Google Scholar
• Deore AB, Dhumane JR, Wagh R, Sonawane R. 2019. The stages of drug discovery and development process. Asian J Pharm Res Dev. 7 (6):62–67. doi: 10.22270/ajprd.v7i6.616.
   Google Scholar
• Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. 1998. Galia1997_evaluation of various media for dissolution testing.pdf. Pharm Res. 15(5):698–705. doi: 10.1023/a:1011910801212.
   PubMed Web of Science ®Google Scholar
• FDA, U S 2018. Draft guidance for industry: bioanalytical method validation, US Department of Health and Human Services. Food and drug administration, center for drug evaluation and research (CDER), center for veterinary medicine (CV). Rockville, MD. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf.
   Google Scholar
• Glomme A, März J, Dressman JB. 2005. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci. 94 (1):1–16. doi: 10.1002/jps.20212.
   PubMed Web of Science ®Google Scholar
• Gonzalez D, Schmidt S, Derendorf H. 2013. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin Microbiol Rev. 26 (2):274–288. doi: 10.1128/CMR.00092-12.
   PubMed Web of Science ®Google Scholar
• Hughes JP, Rees SS, Kalindjian SB, Philpott KL. 2011. Principles of early drug discovery. Br J Pharmacol. 162 (6):1239–1249. doi: 10.1111/j.1476-5381.2010.01127.x.
   PubMed Web of Science ®Google Scholar
• Kanu AB. 2021. Recent developments in sample preparation techniques combined with high-performance liquid chromatography: a critical review. J Chromatogr A. 1654:462444. doi: 10.1016/j.chroma.2021.462444.
   PubMed Web of Science ®Google Scholar
• Kendler DL, Cosman F, Stad RK, Ferrari S. 2022. Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther. 39 (1):58–74. doi: 10.1007/s12325-021-01936-y.
   PubMed Web of Science ®Google Scholar
• Khosla S, Hofbauer LC. 2017. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 5 (11):898–907. doi: 10.1016/S2213-8587(17)30188-2.
   PubMed Web of Science ®Google Scholar
• Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, et al. 2019. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B. 9 (6):1113–1144. doi: 10.1016/j.apsb.2019.10.001.
   PubMed Web of Science ®Google Scholar
• Luan X, Tian X, Zhang H, Huang R, Li N, Chen P, Wang R. 2019. Exercise as a prescription for patients with various diseases. J Sport Health Sci. 8 (5):422–441. doi: 10.1016/j.jshs.2019.04.002.
   PubMed Web of Science ®Google Scholar
• Mamada H, Iwamoto K, Nomura Y, Uesawa Y. 2021. Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans. Mol Divers. 25 (3):1261–1270. doi: 10.1007/s11030-021-10186-7.
   PubMed Web of Science ®Google Scholar
• Mehrotra N, Lal J, Puri SK, Madhusudanan KP, Gupta RC. 2007. In vitro and in vivo pharmacokinetic studies of bulaquine (Analogue of Primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey—highlighting species similarities and differences. Biopharm Drug Dispos. 28 (5):209–227. doi: 10.1002/bdd.547.
   PubMed Web of Science ®Google Scholar
• Natesan V, Kim SJ. 2022. Metabolic bone diseases and new drug developments. Biomol Ther. 30 (4):309–319. doi: 10.4062/biomolther.2022.007.
   PubMed Web of Science ®Google Scholar
• Raju KSR, Rashid M, Gundeti M, Taneja I, Malik MY, Singh SK, Chaturvedi S, Challagundla M, Singh SP, Gayen JR, et al. 2019. LC-ESI-MS/MS method for the simultaneous determination of isoformononetin, daidzein, and equol in rat plasma: application to a preclinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 1129:121776. doi: 10.1016/j.jchromb.2019.121776.
   PubMed Web of Science ®Google Scholar
• Rama Raju KS, Taneja I, Singh SP, Tripathi A, Mishra DP, Mahaboob Hussain K, Gayen JR, Singh SK, Wahajuddin M. 2015. Simultaneous determination of centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS/MS. Bioanalysis. 7 (8):967–979. doi: 10.4155/bio.14.253.
   PubMed Web of Science ®Google Scholar
• Rashid M, Singh SK, Malik MY, Jahan S, Chaturvedi S, Taneja I, Raju KS, Naseem Z, Gayen JR, Wahajuddin M. 2018. Development and validation of uplc-ms/ms assay for quantification of cladrin: absolute bioavailability and dose proportionality study in rats. J Pharm Biomed Anal. 152:289–297. doi: 10.1016/j.jpba.2018.01.044.
   PubMed Web of Science ®Google Scholar
• Riyazuddin M, Husain A, Valicherla GR, Verma S, Gupta AP, Praveena KS, Singh A, Avula SR, Sashidhara KV, Datta D, et al. 2019. Development and validation of LC-MS/MS method for quantification of novel PP2A – β-catenin signalling inhibitor, S011-2111 in mice plasma: application to its preclinical pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 1130–1131 :121829. doi: 10.1016/j.jchromb.2019.121829.
   PubMed Web of Science ®Google Scholar
• Sardar A, Ansari A, Gupta S, Sinha S, Pandey S, Rai D, Kumar M, Bhatta RS, Trivedi R, Sashidhara KV. 2022. Design, synthesis and biological evaluation of new quinazolinone-benzopyran-indole hybrid compounds promoting osteogenesis through bmp2 upregulation. Eur J Med Chem. 244:114813. doi: 10.1016/j.ejmech.2022.114813.
   PubMed Web of Science ®Google Scholar
• Sharma GN, Mohan Singhal M, Sharma KK, Sanadya J. 2010. trouble shooting during bioanalytical estimation of drug applications of bioanalysis LC-MS/MS bioanalysis. Pharm Technol. 1 (1):1–10.
   Google Scholar
• Singh SK, Valicherla GR, Bikkasani AK, Cheruvu SH, Hossain Z, Taneja I, Ahmad H, Raju KSR, Sangwan NS, Singh SK, et al. 2021. Elucidation of plasma protein binding, blood partitioning, permeability, CYP phenotyping and CYP inhibition studies of withanone using validated UPLC method: an active constituent of neuroprotective herb Ashwagandha. J Ethnopharmacol. 270:113819. doi: 10.1016/j.jep.2021.113819.
   PubMed Web of Science ®Google Scholar
• Sozen T, Ozisik L, Calik Basaran N. 2017. An overview and management of osteoporosis. Eur J Rheumatol. 4 (1):46–56. doi: 10.5152/eurjrheum.2016.048.
   PubMed Web of Science ®Google Scholar
• Strom SC, Davila J, Grompe M. 2010. Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol. 640:491–509. doi: 10.1007/978-1-60761-688-7_27.
   PubMedGoogle Scholar
• Taylor S, Harker A. 2006. Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids. J Pharm Biomed Anal. 41 (1):299–303. doi: 10.1016/j.jpba.2005.10.031.
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R. 2010. Bioanalytical method validation: an updated review. Pharm Methods. 1 (1):25. doi: 10.4103/2229-4708.72226.
   PubMedGoogle Scholar
• Valicherla GR, Italiya KS, Gupta CP, Mishra S, Riyazuddin M, Syed AA, Singh SK, Shahi S, Taneja G, Wahajuddin M, et al. 2018. Evaluation of oral pharmacokinetics, in vitro metabolism, blood partitioning and plasma protein binding of novel antidiabetic agent, s009-0629 in rats. Drug Dev Res. 79 (4):173–183. doi: 10.1002/ddr.21433.
   PubMed Web of Science ®Google Scholar
• Verma SK, Biswas A, Kumar M, Mishra A, Choudhury AD, Agrawal S, Sanap SN, Bisen AC, Sharma AK, Panda G, et al. 2022. Preclinical pharmacokinetics, CYP phenotyping, and tissue distribution study of novel anti-breast cancer candidate S-011-1559. Xenobiotica. 52 (5):476–487. doi: 10.1080/00498254.2022.2101033.
   PubMed Web of Science ®Google Scholar
• Verma SK, Biswas A, Saxena S, Kumar M, Mishra A, Choudhury AD, Mishra T, Rais N, Narender T, Bhatta RS. 2023. Development of a sensitive and selective bioanalytical method of chebulinic acid by liquid chromatography-electrospray tandem mass spectrometry and its pharmacokinetic application. Separation Science Plus. 6 (2):1–14. doi: 10.1002/sscp.202200125.
   Web of Science ®Google Scholar
• Walker DK. 2004. The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development. Br J Clin Pharmacol. 58 (6):601–608. doi: 10.1111/j.1365-2125.2004.02194.x.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zheng YL, Wang R, Wang XQ, Zhang H. 2022. Exercise for osteoporosis: a literature review of pathology and mechanism. Front Immunol. 13(September):1005665. doi: 10.3389/fimmu.2022.1005665.
   PubMed Web of Science ®Google Scholar